| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/20/1996 | WO1996018381A1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides |
| 06/20/1996 | WO1996018380A1 Use of flavonoids for protecting unstable cosmetic active substances and constituents in cosmetic and dermatological formulations |
| 06/20/1996 | WO1996018379A1 Cosmetic and dermatological preparations with flavonoids |
| 06/20/1996 | WO1996018372A2 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 06/20/1996 | WO1996015234A3 Lipid-splitting enzyme |
| 06/20/1996 | WO1996014314A3 Thiepane compounds inhibiting and detecting hiv protease |
| 06/20/1996 | WO1996013286A3 Modulation of cell proliferation and wound healing |
| 06/20/1996 | CA2207921A1 Novel receptor |
| 06/20/1996 | CA2207911A1 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 06/20/1996 | CA2207748A1 Cobalt schiff base compounds |
| 06/20/1996 | CA2207626A1 Novel protein tyrosine kinase, jak3 |
| 06/20/1996 | CA2207429A1 Polyarylcarbamoylaza - and - carbamoylalkanedioic acids |
| 06/20/1996 | CA2206890A1 Sphingosine, methylsphingosine and apoptosis |
| 06/20/1996 | CA2206400A1 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 06/20/1996 | CA2205572A1 Chimeric cytokines and uses thereof |
| 06/20/1996 | CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling |
| 06/20/1996 | CA2165517A1 Diamine ethylene derivative used in a cosmetic or dermatologic composition containing a compound with an irritating secondary effect |
| 06/19/1996 | EP0717110A1 LGMD gene |
| 06/19/1996 | EP0717040A1 Thiazine or thiazepine derivatives which inhibit NOS |
| 06/19/1996 | EP0717034A1 Vitamin D compounds and method of preparing these compounds |
| 06/19/1996 | EP0717027A1 Diarylheptanoide derivative and pharmaceutical composition comprising the same |
| 06/19/1996 | EP0716855A2 Use of estrogen agonists for treating prostatic disease, obesity and bone loss |
| 06/19/1996 | EP0716850A1 Use of an ethylene diamine derivative in a cosmetic or dermatological composition and in compositions containing materials with irritant side effects |
| 06/19/1996 | EP0716847A1 Cosmetic or dermatologic compositions containing cinnamic acid derivatives and a flavonoid |
| 06/19/1996 | EP0716661A1 Pseudo- and non-peptide bradykinin receptor antagonists |
| 06/19/1996 | EP0716657A1 ALKOXY-SUBSTITUTED $g(b)-CARBOLINES ACTING ON THE AMPA-RECEPTOR |
| 06/19/1996 | EP0716650A1 Indole and indoline derivatives as 5ht1d receptor antagonists |
| 06/19/1996 | EP0716649A1 5-arylindole derivatives |
| 06/19/1996 | EP0716614A1 Treatment of human tumors by genetic transformation of human tumor cells |
| 06/19/1996 | EP0716610A1 Neural regeneration using human bone morphogenetic proteins |
| 06/19/1996 | EP0716609A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-$g(b) ACTIVITY |
| 06/19/1996 | EP0716603A1 Methods and compositions for inhibiting uridine secretion |
| 06/19/1996 | EP0524173B1 Solubilization and purification of the gastrin releasing peptide receptor |
| 06/19/1996 | CN1124961A Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists |
| 06/19/1996 | CN1124953A Aromatic acetylcholinesterase inhibitors |
| 06/19/1996 | CN1124922A Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
| 06/18/1996 | US5527919 Process for the preparation of 1-[(1,1'-biphenyl]-4-YL]-methyl-1H-imidazole-5-carboxylic acids |
| 06/18/1996 | US5527918 Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid |
| 06/18/1996 | US5527829 HIV protease inhibitors |
| 06/18/1996 | US5527827 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 06/18/1996 | US5527824 Substituted Di-T-Butlyphenols useful for inhibiting leukotriene synthesis |
| 06/18/1996 | US5527817 N,n-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl) ethylamine; selective agonist of 5-ht1-like receptors; useful in treatment of migraines |
| 06/18/1996 | US5527809 Substituted imidazo[4,5-b]pyridines and benzimidazoles |
| 06/18/1996 | US5527807 Treating alopecia, acne, prostate disorders |
| 06/18/1996 | US5527789 Administering a ubiquinone to combat heart failure |
| 06/18/1996 | US5527776 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF |
| 06/18/1996 | US5527703 Genetically engineered proteins for detection of channel modulators, insecticides, anthelmintics |
| 06/18/1996 | US5527546 Human interleukin 6 inhibitor |
| 06/18/1996 | US5527523 Hydroquinone amino-acid esters, methods of preparation, and pharmaceutical or cosmetic compositions containing them |
| 06/18/1996 | CA1338376E Regimen for treating osteoporosis |
| 06/17/1996 | CA2165386A1 2-amino-1,3-thiazepines and their use as inhibitors of nitric oxide synthase |
| 06/15/1996 | CA2164916A1 Vitamin d compounds and method of preparing these compounds |
| 06/15/1996 | CA2164163A1 Diarylheptanoide derivative and pharmaceutical composition comprising the same |
| 06/15/1996 | CA2155627A1 Thiazine- or thiazepine-derivatives |
| 06/13/1996 | WO1996017931A1 Human vascular ibp-like growth factor |
| 06/13/1996 | WO1996017868A1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 06/13/1996 | WO1996017866A1 Novel protein domain which binds tyrosine phosphorylated proteins |
| 06/13/1996 | WO1996017865A2 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 06/13/1996 | WO1996017842A1 Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists |
| 06/13/1996 | WO1996017838A1 Malonic acid based matrix metalloproteinase inhibitors |
| 06/13/1996 | WO1996017617A1 Neuromedin b receptor antagonists |
| 06/13/1996 | WO1996017616A1 Kit for osteoporosis treatment cycle |
| 06/13/1996 | WO1996017609A1 Use of 2-[4-(azolylbutyl)piperazinyl-(methyl)]benzimidazole derivatives for preparing drugs for treating or preventing asthma |
| 06/13/1996 | WO1996017584A2 Combined preparation for stimulating hair growth and optionally nail growth and skin regeneration and for preventing or combatting hair loss |
| 06/13/1996 | WO1996012697A3 Calcium receptor-active compounds |
| 06/13/1996 | WO1996011021A3 Treatment of tissues to reduce subsequent response to injury |
| 06/13/1996 | WO1996006620A3 Lipid analogs for treating viral infections |
| 06/13/1996 | DE19509354A1 Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall Combined preparation for promoting hair growth and possibly the skin and nail growth and to prevent or remedy hair loss |
| 06/13/1996 | CA2207262A1 A novel chemokine expressed in inflamed adenoid, its production and uses |
| 06/13/1996 | CA2207201A1 Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists |
| 06/13/1996 | CA2207028A1 Kit for osteoporosis treatment cycle |
| 06/13/1996 | CA2206994A1 Genes and gene products for use in the diagnosis of degenerative nerve damage |
| 06/13/1996 | CA2206665A1 Malonic acid based matrix metalloproteinase inhibitors |
| 06/13/1996 | CA2205663A1 Neuromedin b receptor antagonists |
| 06/13/1996 | CA2204994A1 A method for enhancing outflow of aqueous humor in treatment of glaucoma |
| 06/13/1996 | CA2182904A1 Use of 2-[4-(azolylbutyl)piperazinyl-(methyl)]benzimidazole derivatives for preparing drugs for treating or preventing asthma |
| 06/12/1996 | EP0716148A2 Recombinant alphavirus vectors |
| 06/12/1996 | EP0716087A1 Heterocyclic amides for control of the potassium channels |
| 06/12/1996 | EP0715855A2 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
| 06/12/1996 | EP0715853A1 Use of glutathione esters for the treatment of pulmonary diseases |
| 06/12/1996 | EP0715627A1 Indole derivatives as thromboxane a2 antagonists |
| 06/12/1996 | EP0715613A1 New diphenylhexene |
| 06/12/1996 | EP0556322B1 Aminosulfonyl urea acat inhibitors |
| 06/12/1996 | EP0451203B1 Modulation of adenylate cyclase response |
| 06/12/1996 | EP0422134B1 5-ht selective agents |
| 06/12/1996 | CN1124491A Inhibitor of stem cell proliferation and uses thereof |
| 06/12/1996 | CN1124486A Heterocycle-containing amidine derivatives, their preparation and use |
| 06/12/1996 | CN1124485A Novel 1-phenylalkanone 5-HT4 receptor ligands |
| 06/12/1996 | CN1124484A 3-(indol-3-YL) propenoic acid derivatives and as NMDA antagonists |
| 06/12/1996 | CN1124483A N-alkylthio polyamine derivatives as radioprotective agents |
| 06/12/1996 | CN1124455A Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/12/1996 | CN1124453A Broiler ascites preventive and method of preventing ascites |
| 06/12/1996 | CN1124142A Oligonucleotides to inhibit the expression of isoprenyl protein transferases |
| 06/12/1996 | CN1124140A Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administration |
| 06/12/1996 | CN1124138A Compositions for treatment of diabetic complications |
| 06/12/1996 | CN1031999C Process for preparing 6-substituted-tetrahydrobenz |CD¨ indoles |
| 06/11/1996 | US5525723 Inhibitors of angiotensin converting enzyme, neutral endopeptidase |
| 06/11/1996 | US5525708 Stabilized protein cell growth and differentiation factors which activate mast cells |
| 06/11/1996 | US5525629 Inhibition of cytokine production |
| 06/11/1996 | US5525624 A 3-benzoyl,4-oxyphenylbenzothiophene compound |